UPLC

Chromatography Instrumentation Market Size to Hit USD 14 Billion by 2035 | Roots Analysis

Retrieved on: 
Monday, January 15, 2024
Research, UPLC, Biotechnology, Thermo Fisher Scientific, QC, Chromatography, Acquisition, Laboratory, Automation, Valmet, Particle size, Growth, Instrumentation

LONDON, Jan. 15, 2024 /PRNewswire/ -- The global chromatography instrumentation market is growing rapidly; it is estimated to be worth USD 7.6 billion in 2023 and is anticipated to reach USD 14 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 5.3% during the forecast period from 2023 to 2035.

Key Points: 
  • Secondly, the chromatography instrumentation market is also driven by the rapidly evolving purification process-specific requirements across different industries.
  • The high cost associated with the development of chromatography instrumentation and operational expenditures are the two major market restraints that impede the growth of the market.
  • The lack of skilled personnel to operate the instrument is considered a key market restraint that restricts the growth of the chromatography instrumentation market.
  • Request Free Sample PDF Copy at:
    Based on the type of chromatography instruments, the market is segmented into liquid chromatography, gas chromatography, and other systems.

Chromatography Instrumentation Market Size to Hit USD 14 Billion by 2035 | Roots Analysis

Retrieved on: 
Monday, January 15, 2024
Research, UPLC, Biotechnology, Thermo Fisher Scientific, QC, Chromatography, Acquisition, Laboratory, Automation, Valmet, Particle size, Growth, Instrumentation

LONDON, Jan. 15, 2024 /PRNewswire/ -- The global chromatography instrumentation market is growing rapidly; it is estimated to be worth USD 7.6 billion in 2023 and is anticipated to reach USD 14 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 5.3% during the forecast period from 2023 to 2035.

Key Points: 
  • Secondly, the chromatography instrumentation market is also driven by the rapidly evolving purification process-specific requirements across different industries.
  • The high cost associated with the development of chromatography instrumentation and operational expenditures are the two major market restraints that impede the growth of the market.
  • The lack of skilled personnel to operate the instrument is considered a key market restraint that restricts the growth of the chromatography instrumentation market.
  • Request Free Sample PDF Copy at:
    Based on the type of chromatography instruments, the market is segmented into liquid chromatography, gas chromatography, and other systems.

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

Retrieved on: 
Wednesday, January 10, 2024
Health, Other Science, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, CITES, Mass spectrometry, UPLC, Multimedia, QPS, Peptide, DMPK, Drug discovery, LC-MS, Laboratory, Therapy, Doctor of Philosophy, Biomarker, HRMS, Oligonucleotide, SFC, Growth, Fine chemical

QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is rapidly expanding its mass spectrometry capacity, adding 13 LC-MS machines in just 15 months at their laboratories in Newark, Delaware (USA) and Groningen, The Netherlands (NL).

Key Points: 
  • QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is rapidly expanding its mass spectrometry capacity, adding 13 LC-MS machines in just 15 months at their laboratories in Newark, Delaware (USA) and Groningen, The Netherlands (NL).
  • View the full release here: https://www.businesswire.com/news/home/20240110198636/en/
    Zamas Lam, PhD, Global Head of Bioanalytical (Mass Spec) & Preclinical Development, QPS LLC.
  • (Photo: Business Wire)
    This expansion includes the impressive growth seen in 2023, when QPS installed seven additional UPLC-(HR)MS/MS tandem instruments - four triple quadrupoles, one QTRAP, and two quadrupole time-of-flight high-resolution mass spectrometers (HRMS).
  • QPS Subject Matter Experts are some of the best in the industry and this new equipment will provide the capacity for them to expand their relationships with our important biotech and pharmaceutical clients,” said Zamas Lam, PhD, Global Head of Bioanalytical (Mass Spec) & Preclinical Development, QPS LLC.

Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging

Retrieved on: 
Monday, June 5, 2023
WAT, Mass spectrometry imaging, American Society for Mass Spectrometry, MALDI, University, Waters, ASMS, Urine, Mass spectrometry, DESI, Sheffield Hallam University, Hope, Research, Noetics, Discovery, Scientific Reports, FWHM, SELECT, Metabolomics, Blood, Drug discovery, MRT, UPLC, Waters Corporation, Society, NYSE, Breast cancer, REM, Television, Medical imaging

HOUSTON, June 5, 2023 /PRNewswire/ -- American Society for Mass Spectrometry (ASMS) -- Waters Corporation (NYSE:WAT) today announced new updates to its SELECT SERIES™ MRT System that increases its specificity and utility for UPLC-MS/MS metabolomics and drug discovery applications and for mass spectrometry imaging experiments. The MRT System now offers 50% higher resolution, making it capable of 300,000 FWHM resolution, a 3X faster scan rate, and parts-per-billion mass accuracy.

Key Points: 
  • New resolution enhancement mode (REM) for Waters' multi-reflecting time-of-flight (MRT) mass spectrometer leads to greater specificity and higher sample throughput for metabolomics UPLC™-MS/MS and MS imaging studies.
  • The MRT System now offers 50% higher resolution, making it capable of 300,000 FWHM resolution, a 3X faster scan rate, and parts-per-billion mass accuracy.
  • It is compatible with numerous MS imaging sources including DESI and MALDI, and generates crystal-clear, high-resolution images without compromising mass spectral resolution or accuracy.
  • The new resolution enhancement mode is available as an optional upgrade to currently installed and new SELECT SERIES MRT Systems.

Woodstock Sterile Solutions Completes Analytical Lab Expansion, Becomes One-Stop Shop CDMO

Retrieved on: 
Wednesday, March 22, 2023
UPLC, BFS, CDMO, Particle size, Risk, HPLC, Fine chemical, Medical device, Typesetting

Expansion doubles the size of the Company's laboratory, building on its analytical expertise, expanding capabilities

Key Points: 
  • Woodstock, Illinois--(Newsfile Corp. - March 22, 2023) - Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), has completed an expansion of its quality control analytical laboratory at its production facility in Woodstock, Illinois.
  • "At Woodstock Sterile Solutions, quality is our passion, and with this investment, we are further developing our in-house quality control program," says, CEO Paul Josephs.
  • Having manufacturing and testing all under one roof also helps us to deliver on our promise to be a one-stop-shop CDMO for customers," says Dr. Kuljit Bhatia, Chief Scientific Officer at Woodstock Sterile Solutions.
  • Woodstock Sterile Solutions has completed an expansion of its quality control analytical laboratory.

Global Analytical Laboratory Services Market Report 2022: Favorable Government Policies to Strengthen Analytical Testing Capabilities Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Other Science, Science, Growth, Ansoff Matrix, Hospital, Clifton Springs Hospital & Clinic, Cardiology, UPLC, Infection, Food, Research, Mass spectrometry, Risk, Environmental monitoring, Immunogenicity, USD, Geography, Government, SWOT, Informal Methods (Validation and Verification), Raw material, Medication, Stability testing, Neurology, Market development, Investment, Fine chemical, Healthcare, BioAnalyt, Serology, Gastroenterology, Oncology, Application, Immunochemistry

The Global Analytical Laboratory Services Market is segmented based on Test Type, Method Type, Sevice Type, Technology, Application, End-Users, and Geography.

Key Points: 
  • The Global Analytical Laboratory Services Market is segmented based on Test Type, Method Type, Sevice Type, Technology, Application, End-Users, and Geography.
  • By Method Type, the market is classified into Pharmacokinetic Testing, Biomarker Testing, Virology Testing, Cell-Based Assays, Immunogenicity, and Serology.
  • The report presents a detailed Ansoff matrix analysis for the Global Analytical Laboratory Services Market.
  • The analyst analyses the Global Analytical Laboratory Services Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford

Retrieved on: 
Friday, October 7, 2022
Software, Research, Pharmaceutical, Oncology, Technology, Other Manufacturing, Health Technology, Science, Biotechnology, Manufacturing, Other Science, Health, News, Korea Carbon Capture & Sequestration R&D Center, IDA, Government, Growth, Diagnosis, Laboratory, Employment, HPLC, NYSE, UPLC, Hospital, Research, Waters Corporation, Global Operations, Waters, Workforce, Science and technology in Asia, Multimedia, High-performance liquid chromatography, WAT, Partnership, R, Software, IVD, Industry, Mass spectrometry, CEO, Ortho Clinical Diagnostics, Enterprise, Renewable energy, Medical device, Medical imaging, IDA Ireland, Corporation

Waters is formally making the announcement at its Wexford campus this afternoon with government and business leaders to mark 25 years of doing business in Ireland.

Key Points: 
  • Waters is formally making the announcement at its Wexford campus this afternoon with government and business leaders to mark 25 years of doing business in Ireland.
  • This 6 million R&D investment will further improve Waters mass spectrometry offerings for clinical diagnostics, he continued.
  • Waters Corporation is a global leader and a significant employer in Wexford where it has operated for 25 years.
  • This announcement by Waters to expand its site in Wexford is very welcome news, said Martin Shanahan, CEO of IDA Ireland.

Emery Pharma Announces New Biologics Analytical Division

Retrieved on: 
Wednesday, August 17, 2022
Molecule, UPLC, DAD, HPLC, Mass spectrometry, Drug discovery, CAD, Refractive index, GLOBE, Charged aerosol detector, Abbott, Microbiology, Alcon, Research, Data management, Pfizer, GC-MS, Client, Data analysis, Cell biology, CSO, Novartis, Gas chromatography–mass spectrometry, Solution, Fine chemical

ALAMEDA, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-Resolution Orbitrap Mass Spectrometer, enabling Emery Pharma to expand its service offerings.

Key Points: 
  • ALAMEDA, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-Resolution Orbitrap Mass Spectrometer, enabling Emery Pharma to expand its service offerings.
  • We are excited for him to lead the new Large Molecule Analytical Division at Emery Pharma," said Dr. Neel Bose, CSO.
  • Emery Pharma is a full-service contract research laboratory, specializing in supporting preclinical drug development, including analytical, bioanalytical solutions, microbiology & cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support.
  • Emery Pharma is equipped to support the development of small molecule drugs, biologics, biosimilars, gene therapies, botanical drugs, and more.

Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins

Retrieved on: 
Tuesday, July 26, 2022
Software, Research, Sustainability, Technology, Agriculture, Natural Resources, Environment, Fitness & Nutrition, Science, Climate Change, Health, Food Tech, Other Science, University of Minnesota College of Food, Agricultural and Natural Resource Sciences, Food, University, Population growth, Aviation, Chromatography, UPLC, Industry, Protein, Human, Boston Consulting Group, NYSE, Research, Organic acid, Software, Climate change, Waters Corporation, Health, Multimedia, Organization, Enterprise, Taste, Waters, Technology, Tendon, CO2, WAT, Life, Workflow, Mass spectrometry, PPIC, Dietary supplement, Renewable energy, Aquaculture

Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY Premier UPLC System .

Key Points: 
  • Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY Premier UPLC System .
  • Waters is the first analytical instrument company to become a member of the PPIC, an industry-leading interdisciplinary research center dedicated to studying plant and alternative proteins.
  • PPIC and its member organizations are, therefore, thrilled to partner with Waters to advance our analytical capabilities for the alternative protein market.
  • i Morach, Benjamin et al, The Untapped Climate Opportunity in Alternative Proteins , Boston Consulting Group, July 8, 2022.

Global Bioanalytical Testing Services Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 12, 2022
Health, Biotechnology, Serum, CSF, Blood, POC, Urine, Coronavirus, Infection, Breast milk, Vaccine, Health, Workflow, Saliva, COVID-19, Robotics, Method, Mass spectrometry, Industry, Cerebrospinal fluid, Plasma, Biomarker, Drug development, UPLC, Growth, Immunochemistry, Pharmaceutical industry, Potash

Bioanalytical testing services are used for the quantitative determination of drugs concentration and their metabolites and pharmacodynamic biomarkers in biological fluids.

Key Points: 
  • Bioanalytical testing services are used for the quantitative determination of drugs concentration and their metabolites and pharmacodynamic biomarkers in biological fluids.
  • How has the global bioanalytical testing services market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bioanalytical testing services market?
  • What is the structure of the global bioanalytical testing services market and who are the key players?